Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance

Clinical antimicrobial susceptibility breakpoints are used to predict the clinical outcome of antimicrobial treatment. In contrast, microbiologic breakpoints are used to identify isolates that may be categorized as susceptible when applying clinical breakpoints but harbor resistance mechanisms that...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Lim, Sue, Bast, Darrin, McGeer, Allison, de Azavedo, Joyce, Low, Donald E.
Format: Artigo
Jezik:Inglês
Izdano: Centers for Disease Control and Prevention 2003
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3023429/
https://ncbi.nlm.nih.gov/pubmed/12890324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid0907.020589
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items